According to Dr. Seth Berkley, CEO of Gavi, within the last 10 years, the pneumonia vaccine has saved the lives of more than 500,000 children in developing countries. More than 109 million children have been given the PCV (pneumococcal conjugate vaccine) with Gavi’s support.
Although the numbers have now reached 41 percent from 2015’s 35 percent of receiver rates, millions of children are still not receiving the pneumonia vaccine. This is an issue because the disease is both treatable and preventable, but remains the leading cause of death in children throughout the world.
The pneumococcal vaccination protects the body against different types of the pneumococcal bacteria itself. The pneumonia disease is most common in children, and therefore the CDC recommends that all children be vaccinated. Although there are many different types of pneumococcal bacteria, there are only two types of the vaccination itself. The first vaccination to fight pneumonia is called Prevnar 13. This vaccination protects against 13 different types of the pneumococcal bacteria. The second type, Pneumovax 23, protects against 23 different types of the bacteria. Although this vaccine can save lives and prevent the disease, children in developing countries are nine times more likely to get the disease than people in developed countries.
Normally, children in developing countries receive vaccinations 10 years after children in wealthy countries do, but with the Advance Market Commitment, funded by Italy, Canada, Russia, Norway and the Bill and Melinda Gates Foundation, they were able to get the PCV vaccine as soon as a year after it was developed. The market legally binds commitment purchases of the vaccinations through preset terms. This concept has been around for a long time, but the Advanced Market Commitment’s tactics seem to be very effective. Gavi has reached 58 countries throughout Africa and Asia with their immunization programs. The continued push to immunize all children in developing countries will greatly affect these nations’ outcomes in the future.
– Chloe Turner
Photo: Flickr
An outbreak of the pneumonic plague is threatening citizens and affecting many areas of
Cardiovascular diseases cause a large number of deaths around the world. Unfortunately, treating cardiovascular diseases in 
On October 19, an official outbreak of the
Water quality in Guatemala has become an increasingly important issue because the country is facing one of its
Located in Southeast Asia,
Located on the western side of Africa is Gambia, the
The 10/90 Gap is the idea that 10 percent of the world’s health research potential is devoted to conditions which make up 90 percent of the Global Burden of Disease (GBD). Activists who proposed the 10/90 gap claim that the majority of diseases present in the developing world have been neglected and research for these diseases has been drastically overlooked and underfunded.
Located in the Indian Ocean off the coast of Southern Africa, Mauritius is an archipelago that is only about 500 miles east of 